Zeitschrift fur Epileptologie

Scope & Guideline

Enhancing understanding of epilepsy through research.

Introduction

Welcome to the Zeitschrift fur Epileptologie information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Zeitschrift fur Epileptologie, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageGerman
ISSN1617-6782
PublisherSPRINGER HEIDELBERG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 2005 to 2022
AbbreviationZ EPILEPTOL / Z. Epileptol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY

Aims and Scopes

The journal 'Zeitschrift für Epileptologie' focuses on advancing the understanding of epilepsy through a multidisciplinary approach that encompasses clinical research, treatment methodologies, and the psychosocial aspects of living with epilepsy. It aims to provide a platform for scholarly communication among researchers, clinicians, and healthcare providers in the field of epileptology.
  1. Clinical Management of Epilepsy:
    The journal emphasizes clinical studies and reviews that explore various management strategies for epilepsy, including drug therapies, surgical interventions, and innovative treatment options like vagus nerve stimulation.
  2. Epidemiology and Public Health:
    Research on the epidemiological aspects of epilepsy, particularly in specific populations such as the elderly and those with intellectual disabilities, is a consistent focus, highlighting the public health implications of the disorder.
  3. Neuropsychology and Comorbidities:
    The journal addresses the neuropsychological impact of epilepsy, including cognitive and emotional challenges faced by patients, and the interplay of epilepsy with other comorbidities such as cardiovascular diseases and developmental disorders.
  4. Innovative Technologies in Epilepsy Care:
    A unique contribution of the journal includes the exploration of telemedicine, mobile health technologies, and wearable devices for improving patient care and monitoring in epilepsy, reflecting a modern approach to treatment.
  5. Surgical Techniques and Outcomes:
    It regularly publishes studies and reviews on surgical techniques for epilepsy, including presurgical evaluations and postoperative outcomes, contributing to the understanding of when and how surgical interventions can be beneficial.
Recent publications in 'Zeitschrift für Epileptologie' indicate several emerging themes that reflect the evolving landscape of epilepsy research and clinical practice. These trends highlight the journal's responsiveness to current challenges and advancements in the field.
  1. Aging and Epilepsy:
    There is an increasing focus on epilepsy in older adults, including studies on epidemiology, management of status epilepticus, and the implications of aging on treatment efficacy and patient outcomes.
  2. Intellectual Disability and Epilepsy:
    The intersection of epilepsy with intellectual disabilities is gaining attention, with a rise in research addressing specific challenges and treatment options for this population, emphasizing the need for tailored approaches.
  3. Telemedicine and Digital Health:
    The integration of telemedicine and digital health technologies into epilepsy care is emerging as a significant theme, as the journal explores the implications of remote monitoring and virtual consultations for improving patient management.
  4. Precision Medicine in Epilepsy:
    The concept of precision medicine, which tailors treatment based on individual patient characteristics, is increasingly featured, reflecting a broader trend towards personalized approaches in the management of epilepsy.
  5. Surgical Innovations:
    Research on innovative surgical techniques and their outcomes is trending, with a focus on minimally invasive procedures and advancements in surgical technology that enhance patient care.

Declining or Waning

While 'Zeitschrift für Epileptologie' continues to expand its scope in several areas, some themes appear to be waning in prominence. This may reflect shifts in research focus, clinical priorities, or advancements in treatment methodologies.
  1. Focus on Traditional Antiepileptic Drugs:
    There is a noticeable decline in publications centered on traditional antiepileptic drugs as newer therapies and treatment approaches gain traction, indicating a shift toward more innovative treatment methods.
  2. Historical Perspectives on Epileptology:
    Papers discussing historical aspects of epileptology and past figures in the field are becoming less frequent, suggesting a shift towards contemporary issues and future directions rather than retrospectives.
  3. Generalized Epilepsy Types:
    Research focusing on generalized epilepsy types appears to be decreasing, possibly as more attention is directed toward focal epilepsies and specific syndromes, which are often more complex and challenging to manage.

Similar Journals

Journal of the Practice of Cardiovascular Sciences

Innovating Solutions in Cardiovascular Health
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

EPILEPSY & BEHAVIOR

Elevating the discourse on epilepsy and its behavioral implications.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1525-5050Frequency: 12 issues/year

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

Tumori Journal

Transforming Cancer Research into Clinical Practice.
Publisher: SAGE PUBLICATIONS LTDISSN: 0300-8916Frequency: 6 issues/year

Tumori Journal is a distinguished publication in the field of oncology, dedicated to advancing the understanding and treatment of cancer since its inception in 1946. Published by SAGE Publications Ltd, this Italian journal serves as a pivotal platform for researchers, clinicians, and academicians to disseminate cutting-edge findings in cancer research and related areas of medicine. With an impressive record of contributions spanning multiple decades, Tumori Journal aims to foster collaboration and dialogue among professionals in the oncology community. Although classified in the Q4 category for Cancer Research and the Q3 category for both Medicine (miscellaneous) and Oncology as of 2023, the journal continues to draw interest with its rigorous peer-review process and commitment to quality. Researchers are encouraged to explore innovative methodologies and share impactful clinical insights through the journal, which also ranks within the top tiers of Scopus metrics for oncology and cancer research domains. With a growing emphasis on accessible research, Tumori Journal remains an essential resource in the continuous fight against cancer.

EPILEPSIA

Charting new paths in epilepsy understanding.
Publisher: WILEYISSN: 0013-9580Frequency: 12 issues/year

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.

REVUE NEUROLOGIQUE

Advancing Neurological Science with Every Issue
Publisher: MASSON EDITEURISSN: 0035-3787Frequency: 10 issues/year

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

Movement Disorders Clinical Practice

Navigating the complexities of movement disorders together.
Publisher: WILEYISSN: 2330-1619Frequency: 8 issues/year

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

Andes Pediatrica

Advancing pediatric knowledge for a healthier tomorrow.
Publisher: SOC CHILENA PEDIATRIAISSN: Frequency: 6 issues/year

Andes Pediatrica is an esteemed open-access journal published by the SOC CHILENA PEDIATRIA that has been at the forefront of pediatric research since its inception in 2021. Based in Chile, the journal aims to enhance knowledge and dissemination of innovative findings in the fields of pediatrics, perinatology, and child health, making significant contributions to the wellbeing of young populations. With a commitment to open access, it facilitates widespread availability of research, ensuring that crucial information reaches clinicians, researchers, and policymakers globally. Despite its recent launch, Andes Pediatrica has already secured a respectable position within the academic community, reflecting its rank in the Q3 category for 2023 in Pediatrics as per Scopus rankings. By fostering a collaborative environment for sharing cutting-edge research, the journal plays a vital role in addressing contemporary challenges in child health, ultimately striving to improve health outcomes for children both in Chile and beyond.

HAEMOPHILIA

Unraveling complexities in blood disorders.
Publisher: WILEYISSN: 1351-8216Frequency: 6 issues/year

HAEMOPHILIA is a leading peer-reviewed journal published by Wiley, dedicated to advancing research and clinical practices in the fields of hematology and genetics. With an impressive Impact Factor and recognition within the Q1 category for Genetics (clinical), Hematology, and Medicine (miscellaneous), this journal presents a unique platform for the dissemination of high-quality research from 1995 to the present. Researchers in these dynamic fields will find invaluable insights through original articles, systematic reviews, and clinical trials, all aimed at improving therapeutic strategies and patient outcomes. Although it operates on a subscription basis, HAEMOPHILIA's commitment to excellence is reflected in its Scopus rankings, where it stands in the 74th percentile for hematology and the 71st percentile for clinical genetics. As an essential resource for academics, healthcare professionals, and students, HAEMOPHILIA plays a pivotal role in fostering innovation and collaboration within the global medical community.

Obesity Research & Clinical Practice

Elevating Standards in Obesity Health and Wellness
Publisher: ELSEVIER SCI LTDISSN: 1871-403XFrequency: 6 issues/year

Obesity Research & Clinical Practice is an esteemed journal published by ELSEVIER SCI LTD, focusing on cutting-edge research and clinical practices related to obesity and its multifaceted impact on health and wellness. With an ISSN of 1871-403X and an E-ISSN of 1878-0318, this journal serves as a vital resource for researchers and practitioners in the fields of Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. Notably, it holds a Q2 ranking in Endocrinology, Diabetes and Metabolism and a prestigious Q1 ranking in Nutrition and Dietetics for 2023, reflecting its influence and quality within the scientific community. The journal features a broad scope of research topics encompassing clinical findings, epidemiological studies, and therapeutic advancements in obesity treatment, aiming to improve health outcomes globally. Submissions are encouraged from diverse disciplines, ensuring a dynamic and multidisciplinary approach to tackling obesity-related challenges. Given its convergence of years from 2007 to 2024, Obesity Research & Clinical Practice stands as a prominent platform for disseminating valuable knowledge, insights, and groundbreaking research in this pressing area of public health.

Clinical Obesity

Pioneering Discoveries in Endocrinology and Metabolism
Publisher: WILEYISSN: 1758-8103Frequency: 6 issues/year

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.